Evidence map›Paper›PMID 40391736›Full record

ArticleACS biomaterials science & engineering2025

Changes in Generations of PAMAM Dendrimers and Compositions of Nucleic Acid Nanoparticles Govern Delivery and Immune Recognition.

Yelixza I Avila, Laura P Rebolledo, Nathalia Leal Santos, Brandon Rawlins, Yasmine Radwan, Melanie Andrade-Muñoz, Elizabeth Skelly, Morgan R Chandler, Luciana N S Andrade, Tae Jin Kim and 2 more

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yelixza I AvilaDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.
Laura P RebolledoDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.
Nathalia Leal SantosDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.
Brandon RawlinsDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.
Yasmine RadwanDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.
Melanie Andrade-MuñozDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.
Elizabeth SkellyDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.
Morgan R ChandlerMIMETAS US, Inc, Gaithersburg, Maryland 20878, United States.ORCID 0000-0003-3078-6000
Luciana N S AndradeCenter for Translational Research in Oncology (LIM24), Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Comprehensive Center for Precision Oncology, Universidade de São Paulo, São Paulo 01246-000, Brazil.
Tae Jin KimDepartment of Physical Sciences, West Virginia University Institute of Technology, Beckley, West Virginia 25801, United States.
Marina A DobrovolskaiaNanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland 21702, United States.ORCID 0000-0002-4233-9227
Kirill A AfoninDepartment of Chemistry, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States.ORCID 0000-0002-6917-3183

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responsesR35GM139587 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI AFONIN, KIRILL A · 2021 to 2025
$1.8M
Investigating and Characterizing Non-Viral, Biocompatible Delivery Vehicles for Nucleic Acid NanoparticlesF31GM146479 · NIGMS · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI AVILA, YELIXZA · 2022 to 2023
$77k
NCI NIH HHS 75N91019D00024NIGMS NIH HHS F31 GM146479NIGMS NIH HHS R35 GM139587
6 · The paper itself

Abstract

Nucleic acid nanoparticles (NANPs) are promising immune modulators due to their well-established structural properties and distinct structure-activity relationship with the immune system. We previously identified that NANPs' size, shape, composition, and type of delivery vehicle define their uptake by immune cells and subsequently induced cytokine profile. In this work, we examined the delivery efficiencies and immunological impacts of two representative NANPs─DNA cubes and RNA cubes─complexed with a benchmark delivery vehicle, Lipofectamine 2000 vs. different generations of amine-terminated poly(amidoamine) dendrimers. Using molecular dynamics simulations, we modeled dendrimer interactions with nucleic acid cargos. Next, we used traditional 2D and more recently established 3D cell cultures to assess dendrimers' influence on NANPs uptake. Immune activation was evaluated in several cell lines engineered with reporter genes driven by key immune signaling pathways. Specifically, HEK-lucia reporter cells were used to evaluate RIG-I activation, while THP1-Dual cells provided quantitative readouts for both IRF and NF-κB transcription factor activity. Our findings demonstrate that both dendrimer generation and NANP composition influence cellular uptake and immune responses. This study underscores the importance of formulation in shaping NANPs' biological properties and further advances the understanding of their immunological properties critical for the development of NANPs-based adjuvants.

Indexed as

DendrimersDNANanoparticlesNucleic AcidsRNADEAD Box Protein 58HEK293 CellsHumansMolecular Dynamics SimulationReceptors, ImmunologicTHP-1 CellsDEAD Box Protein 58DendrimersDNANucleic AcidsPAMAM StarburstReceptors, ImmunologicRIGI protein, humanRNAdeliveryimmune responseinterferonsNANPsPAMAM dendrimersspheroids

Identifiers

PMID40391736
PMCPMC12152843

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.